Chini E N, Klener P, Beers K W, Chini C C, Grande J P, Dousa T P
Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minnesota, USA.
Kidney Int. 1997 May;51(5):1500-6. doi: 10.1038/ki.1997.206.
Recent discovery of cyclic ADP-ribose (cADPR) as an agent that triggers Ca2+ release from intracellular stores, through ryanodine receptor channel, is an important new development in the investigation of intracellular signaling mechanisms. We determined the capacity of kidney and its components for synthesis of cADPR from beta-NAD, that is catalyzed by enzyme ADP-ribosyl cyclase, and enzymatic inactivation that is catalyzed by cADPR-glycohydrolase. Little or no activity of ADP-ribosyl cyclase was found in extracts from the whole rat kidney, renal cortex, outer and inner medulla. On the other hand, incubation of beta-NAD with similar extracts from rat liver, spleen, heart, and brain resulted in biosynthesis of cADPR. In addition, extracts from suspension of proximal tubules or microdissected proximal convoluted tubules virtually lacked ADP-ribosyl cyclase activity. In sharp contrast to proximal tubules and cortex, extracts from glomeruli had high ADP-ribosyl cyclase activity, similar to that found in non-renal tissues. Authenticity of cADPR biosynthesized in glomeruli was documented by several criteria such as HPLC analysis, effect of inhibitors and homologous desensitization of Ca(2+)-release bioassay. On the other hand, the activity of cADPR-glycohydrolase was similar in extracts from glomeruli and in extracts from kidney cortex. Mesangial cells and vascular smooth muscle cells grown in primary culture displayed considerable ADPR-ribose cyclase activity. Our results show that extracts from glomeruli, unlike extracts from renal tissue zones and proximal tubules, have a singularly high capacity for synthesis of cADPR. We surmise that cADPR-triggered Ca(2+)-releasing system can serve as an intracellular signaling pathway that may be operant in regulations of glomerular cell functions.
环磷酸腺苷核糖(cADPR)作为一种通过兰尼碱受体通道触发细胞内钙库释放Ca2+的物质,其最近被发现是细胞内信号传导机制研究中的一项重要新进展。我们测定了肾脏及其各组成部分由β-NAD合成cADPR的能力,该合成由ADP-核糖基环化酶催化,以及cADPR-糖水解酶催化的酶促失活。在大鼠全肾、肾皮质、外髓和内髓的提取物中未发现或仅发现极少的ADP-核糖基环化酶活性。另一方面,β-NAD与大鼠肝脏、脾脏、心脏和大脑的类似提取物一起孵育会导致cADPR的生物合成。此外,近端小管悬浮液或显微解剖的近端曲管的提取物几乎没有ADP-核糖基环化酶活性。与近端小管和皮质形成鲜明对比的是,肾小球提取物具有较高的ADP-核糖基环化酶活性,并与非肾组织中的活性相似。通过诸如高效液相色谱分析、抑制剂的作用以及Ca(2+)释放生物测定的同源脱敏等多项标准,证明了在肾小球中生物合成的cADPR的真实性。另一方面,cADPR-糖水解酶在肾小球提取物和肾皮质提取物中的活性相似。原代培养的系膜细胞和血管平滑肌细胞表现出相当高的ADPR-核糖环化酶活性。我们的结果表明,与肾组织区域和近端小管的提取物不同,肾小球提取物具有特别高的合成cADPR的能力。我们推测,cADPR触发的Ca(2+)释放系统可作为一种细胞内信号传导途径,可能在肾小球细胞功能调节中起作用。